| Metric | სს ბიოფარმი | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾10.1m₾9.7m | ₾2.70bn₾2.32bn |
| Revenue growth | 4.8% | 16.6% |
| Profitability | ||
| EBITDA | -₾847k-₾427k | — |
| EBITDA margin | -8.3%-4.4% | — |
| Net profit | -₾1.3m-₾1.1m | ₾1.84bn₾1.33bn |
| Net margin | -12.6%-11.5% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾19.1m₾18.5m | ₾39.27bn₾31.39bn |
| Total equity | ₾18.2m₾17.1m | ₾5.63bn₾4.45bn |
| ROE | -7.0%-6.5% | 32.6%30.0% |